Wille A, Machado M, Souza S, Justa H, Fraga-Ferreira M, Mello E
Toxins (Basel). 2025; 17(2).
PMID: 39998087
PMC: 11860474.
DOI: 10.3390/toxins17020070.
Rodrigues G, de Almeida M, Marcelino S, Fernandes P, da Cruz J, Araujo F
J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20240004.
PMID: 39069986
PMC: 11276892.
DOI: 10.1590/1678-9199-JVATITD-2024-0004.
Azuara-Antonio O, Isidoro Ortiz M, Jimenez-Oliver K, Castillo-Cabrera M, Mendez-Salinas A, Hernandez-Ramirez L
Sao Paulo Med J. 2024; 142(4):e2023151.
PMID: 38422241
PMC: 10885633.
DOI: 10.1590/1516-3180.2023.0151.04012023.
Miranda A, Antunes B, Minozzo J, Lima S, Botelho A, Campos M
Toxins (Basel). 2023; 15(10).
PMID: 37888620
PMC: 10610985.
DOI: 10.3390/toxins15100589.
Justa H, Gonzalez J, Vuitika L, Mariutti R, Magnago P, de Moraes F
Int J Mol Sci. 2023; 24(15).
PMID: 37569382
PMC: 10419089.
DOI: 10.3390/ijms241512006.
Systemic Loxoscelism, Less Frequent but More Deadly: The Involvement of Phospholipases D in the Pathophysiology of Envenomation.
Gremski L, Justa H, Polli N, Schluga P, Theodoro J, Wille A
Toxins (Basel). 2023; 15(1).
PMID: 36668837
PMC: 9864854.
DOI: 10.3390/toxins15010017.
Temporal evolution of dermonecrosis in loxoscelism assessed by photodocumentation.
Borrasca-Fernandes C, Prado C, Capitani E, Hyslop S, Bucaretchi F
Rev Soc Bras Med Trop. 2022; 55:e0502.
PMID: 35239909
PMC: 8909434.
DOI: 10.1590/0037-8682-0502-2021.
Viscerocutaneous Loxoscelism Manifesting with Myocarditis: A Case Report.
Langner T, Ganatra H, Schwerdtfager J, Stoecker W, Thornton S
Am J Case Rep. 2021; 22:e932378.
PMID: 34453029
PMC: 8409453.
DOI: 10.12659/AJCR.932378.
Brown spider venom toxins: what are the functions of astacins, serine proteases, hyaluronidases, allergens, TCTP, serpins and knottins?.
Gremski L, Matsubara F, Justa H, Schemczssen-Graeff Z, Baldissera A, Schluga P
J Venom Anim Toxins Incl Trop Dis. 2021; 27:e20200188.
PMID: 34377142
PMC: 8314928.
DOI: 10.1590/1678-9199-JVATITD-2020-0188.
Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.
Gremski L, Matsubara F, Polli N, Antunes B, Schluga P, Justa H
Front Mol Biosci. 2021; 8:706704.
PMID: 34222343
PMC: 8247472.
DOI: 10.3389/fmolb.2021.706704.
Brown Spiders' Phospholipases-D with Potential Therapeutic Applications: Functional Assessment of Mutant Isoforms.
Silva T, de Castro F, Vuitika L, Polli N, Antunes B, Boia-Ferreira M
Biomedicines. 2021; 9(3).
PMID: 33801128
PMC: 8004160.
DOI: 10.3390/biomedicines9030320.
Synanthropic spiders, including the global invasive noble false widow Steatoda nobilis, are reservoirs for medically important and antibiotic resistant bacteria.
Dunbar J, Khan N, Abberton C, Brosnan P, Murphy J, Afoullouss S
Sci Rep. 2020; 10(1):20916.
PMID: 33262382
PMC: 7708416.
DOI: 10.1038/s41598-020-77839-9.
Biotechnological potential of Phospholipase D for antivenom development.
Fingermann M, de Roodt A, Cascone O, Miranda M
Toxicon X. 2020; 6:100036.
PMID: 32550591
PMC: 7286061.
DOI: 10.1016/j.toxcx.2020.100036.
Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.
Karim-Silva S, Becker-Finco A, Jiacomini I, Boursin F, Leroy A, Noiray M
Toxins (Basel). 2020; 12(4).
PMID: 32316084
PMC: 7232456.
DOI: 10.3390/toxins12040256.
Clinical aspects, diagnosis and management of Loxosceles spider envenomation: literature and case review.
Lopes P, Squaiella-Baptistao C, Marques M, Tambourgi D
Arch Toxicol. 2020; 94(5):1461-1477.
PMID: 32232511
DOI: 10.1007/s00204-020-02719-0.
Forty Years of the Description of Brown Spider Venom Phospholipases-D.
Gremski L, Justa H, Silva T, Polli N, Antunes B, Minozzo J
Toxins (Basel). 2020; 12(3).
PMID: 32155765
PMC: 7150852.
DOI: 10.3390/toxins12030164.
Loxoscelism: Cutaneous and Hematologic Manifestations.
Nguyen N, Pandey M
Adv Hematol. 2019; 2019:4091278.
PMID: 31015839
PMC: 6446102.
DOI: 10.1155/2019/4091278.
Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies Against Spider Venom.
Calabria P, Shimokava-Falcao L, Colombini M, Moura-da-Silva A, Barbaro K, Faquim-Mauro E
Toxins (Basel). 2019; 11(2).
PMID: 30759862
PMC: 6409891.
DOI: 10.3390/toxins11020108.
Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism.
Lopes P, Murakami M, Portaro F, Pasqualoto K, van den Berg C, Tambourgi D
J Enzyme Inhib Med Chem. 2019; 34(1):310-321.
PMID: 30734604
PMC: 6327989.
DOI: 10.1080/14756366.2018.1546698.
Viscerocutaneous Loxoscelism in an Adult with Acute Generalized Exanthematous Pustulosis.
Mueller M, Doucette E, Freeman S, Williams A, Lindbloom E
Mo Med. 2018; 111(2):139-142.
PMID: 30323527
PMC: 6179493.